Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.4K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.4K
Structure and Function of Platelets01:18

Structure and Function of Platelets

4.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.0K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

338
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
338
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Membrane Asymmetry Regulating Transporters01:19

Membrane Asymmetry Regulating Transporters

7.6K
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis.

Clinical and experimental immunology·2015
Same author

An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Transcriptional profiling of liver and effect of glucocorticoids in a rat adjuvant-induced arthritis model.

Veterinary pathology·2010
Same author

Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch1alpha).

International immunology·2001
Same author

Reduced levels of Hsp70 result in a therapeutic effect of 15-deoxyspergualin on acute graft-versus-host disease in (DA x LEW)F1 rats.

Immunobiology·2000

Related Experiment Video

Updated: Feb 22, 2026

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

1.2K

Putrescine transport in human platelets.

S G Nadler, M T Takahashi

    Biochimica Et Biophysica Acta
    |January 25, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Human platelets transport putrescine via an energy-dependent, complex process. Researchers identified specific membrane proteins involved, suggesting a link to the serotonin transport system.

    More Related Videos

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
    05:49

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

    Published on: November 29, 2024

    1.2K
    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
    09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    12.5K

    Related Experiment Videos

    Last Updated: Feb 22, 2026

    Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
    07:06

    Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

    Published on: January 10, 2025

    1.2K
    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
    05:49

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

    Published on: November 29, 2024

    1.2K
    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
    09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    12.5K

    Area of Science:

    • Biochemistry
    • Cell Biology
    • Pharmacology

    Background:

    • Putrescine is a polyamine crucial for cell growth and function.
    • Understanding polyamine transport in human platelets is vital for various physiological processes.

    Purpose of the Study:

    • To investigate the mechanisms of putrescine transport in human platelets.
    • To identify and characterize the proteins involved in this transport process.

    Main Methods:

    • Studied putrescine uptake kinetics and energy dependence using inhibitors and temperature changes.
    • Employed differential labeling with N-ethylmaleimide and SDS-polyacrylamide gel electrophoresis.
    • Utilized putrescine affinity chromatography for protein purification.
    • Investigated the effect of imipramine on putrescine transport.

    Main Results:

    • Putrescine uptake is saturable, energy-dependent, and influenced by pH and membrane potential.
    • Identified membrane proteins of 55,000 and 65,000 molecular weights involved in transport.
    • Putrescine protected against N-ethylmaleimide inhibition, confirming protein involvement.
    • Imipramine inhibited putrescine transport, suggesting a link to the serotonin transporter.

    Conclusions:

    • Human platelet putrescine transport is a complex, protein-mediated process.
    • Specific membrane proteins are implicated in putrescine uptake.
    • The serotonin transport system may be involved in putrescine transport.